Welcome : Guest

Supernus Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Supernus Pharmaceuticals, Inc., which is principally involved in Specialty Pharmaceuticals Business. Illustrated with 27 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65473
Price: $1350
Company Type: Public
Pages: 30
Date: January 2017
Market Data Tables: 27

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Active Pharmaceutical Ingredients (API)......4
Table 1: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs......4
Table 2: Generic Active Pharmaceutical Ingredients Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Avapro Avalide, Benicar HCT, Cozaar Hyzaar, Diovan HCT, and Others......5
Table 3: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2015) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......6
Table 4: Pharmaceuticals Services and Active Ingredients (PSAI) Segment Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America and Rest of the World......7
Table 5: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing......8
Anti-Psychotics......9
Table 6: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......9
Table 7: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......10
Table 8: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......11
Central Nervous System (CNS) Drugs......12
Table 9: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......12
Table 10: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......13
Depression Drugs......14
Table 11: Depression Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Bupropion Hydrochloride XL, Cymbalta, Escitalopram Oxalate, Lexapro, Pristiq, and Others......14
Epilepsy Drugs......15
Table 12: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......15
Seizure Disorders......16
Table 13: Seizure Disorder Market by Type of Drug in the US (2015) - Percentage Share Breakdown by Value for Carbamazepine, Clonazepam, Gabapentin, Lamotrigine, Levetiracetam, Valproic Acids and Others......16
Antipsychotic Drugs......17
Table 14: Antipsychotic Drugs Market by Disorder in the US (2015) - Percentage Breakdown by Value for Anxiety, Bipolar, Disorder, Major, Depression, Schizoaffective Disorder, Schizophrenia, and Other Indications......17
Oxcarbazepine Drugs......18
Table 15: Oxcarbazepine Drug Usage by Prescriber in the US (2015) - Percentage Market Share Breakdown by Volume for Internal Medicine & Pediatrics, Neurology, Nurse, Psychiatry, and Others......18
Table 16: Oxcarbazepine Drug Usage by Indication in the US (2015) - Percentage Market Share Breakdown by Volume for Epilepsy, Psychiatric Disorders and Others......19
Topiramate Drugs......20
Table 17: Topiramate Drug Usage by Prescriber in the US (2015) - Percentage Market Share Breakdown by Volume for Family Practice, Internal Medicine & Pediatrics, Neurology, Nurse, Osteopathic Medicine, Psychiatry, and Others......20
Table 18: Topiramate Drug Usage by Indication in the US (2015) - Percentage Market Share Breakdown by Volume for Epilepsy, Migraine Headache, Psychiatric Disorders, Weight Loss, and Others......21
Acute Behavioural Treatment......22
Table 19: Market Shares of Leading Acute Behavioural Treatment Service Providers Worldwide (2015) - Percentage Breakdown by No. of Beds for Accreditation Commission for Health Care, Inc. (ACHC), Aurora Behavioral Health Care, Universal Health Services, Inc., and Others......22
Antipsychotics......23
Table 20: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......23
Table 21: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......24
Table 22: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......25
Central Nervous System (CNS) Medicines......26
Table 23: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......26
Table 24: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......27
Epilepsy Therapeutics......28
Table 25: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......28
Post-Traumatic Stress Disorder (PTSD) Drugs......29
Table 26: Market Shares of Leading Drugs for Post-Traumatic Stress Disorder (PTSD) Treatment in the US (2015) - Percentage Share Breakdown by Value for Citalopram, Clonazepam, Escitalopram, Quetiapine, Quetiapine, Sertraline, and Others......29
Attention Deficit Hyperactivity Disorder (ADHD)......30
Table 27: Market Shares of Leading Drugs for Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the US (2015) - Percentage Share Breakdown by Value for Intuniv, Strattera and Others......30